Intel and Teva team-up to develop wearable tech platform to track Huntington’s disease

Teva Pharmaceutical Industries Ltd said on Thursday it was collaborating with Intel Corp to develop a wearable technology platform to track the progression of disease in patients with Huntington’s, a fatal degenerative disorder.